Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Global health outreach programs can risk benefitting students from resource-rich areas of the world more than the patients in resource-poor areas of the world. This month’s episode of Ethics Talk explores an alternative to academic health center-based health outreach programs.
Weyinshet Gossa, MD, MPH and Michael D. Fetters, MD, MPH, MA
Cervical cancer has become rare in high-income countries but is a leading cause of mortality among women in low- and middle-income countries. This inequity is an epidemiological tragedy.
AMA J Ethics. 2020;22(2):E126-134. doi:
10.1001/amajethics.2020.126.
Alice Wong and Dr Joseph Stramondo join us on this special episode of Ethics Talk to discuss how perspectives from the disability community can help us think more powerfully about quality of life, resource allocation, and other ethical challenges arising in pandemics. Transcript available.
One patient’s experience of life-encompassing iatrogenic harm from being institutionalized emphasizes Italy’s comparative success, relative to the United States, in recovering from decades of deinstitutionalization policy.
AMA J Ethics. 2022;24(8):E795-803. doi:
10.1001/amajethics.2022.795.
Michael Toppe, DMSc, PA-C and Lushiku Nkombua, MD, MMed
American physician assistant students trained in South Africa to study an example of a reverse innovation practice that could be incorporated in the US.
AMA J Ethics. 2023;25(5):E332-337. doi:
10.1001/amajethics.2023.332.